Stock ESTA ESTABLISHMENT LABS HOLDINGS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Establishment Labs Holdings Inc. Stock

Equities

ESTA

VGG312491084

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-26 EDT 		5-day change 1st Jan Change
48.47 USD -0.14% Intraday chart for Establishment Labs Holdings Inc. +2.30% +87.22%
04-03 Citigroup Raises Price Target on Establishment Labs to $60 From $49, Maintains Buy Rating MT
04-02 Establishment Labs Says US FDA Schedules Preapproval Inspection of Motiva Implants Facility MT

Financials

Sales 2024 * 181M 247M Sales 2025 * 243M 333M Capitalization 1.33B 1.82B
Net income 2024 * -47M -64.24M Net income 2025 * -19M -25.97M EV / Sales 2024 * 8.46 x
Net Debt 2024 * 197M 269M Net Debt 2025 * 201M 275M EV / Sales 2025 * 6.3 x
P/E ratio 2024 *
-27.9 x
P/E ratio 2025 *
-67.3 x
Employees 908
Yield 2024 *
-
Yield 2025 *
-
Free-Float 85.8%
More Fundamentals * Assessed data

Chart Establishment Labs Holdings Inc.

Dynamic Chart

Latest news about Establishment Labs Holdings Inc.

Citigroup Raises Price Target on Establishment Labs to $60 From $49, Maintains Buy Rating MT
Establishment Labs Says US FDA Schedules Preapproval Inspection of Motiva Implants Facility MT
Mizuho Securities Raiset Price Target on Establishment Labs to $65 From $50, Keeps Buy Rating MT
TD Cowen Adjusts Establishment Labs Price Target to $60 From $50, Maintains Outperform Rating MT
Transcript : Establishment Labs Holdings Inc. Presents at Citi?s 2024 Unplugged Medtech and Life Sciences Access Day, Feb-29-2024 02:30 PM
Transcript : Establishment Labs Holdings Inc., Q4 2023 Earnings Call, Feb 28, 2024
Establishment Labs Holdings Inc. Provides Revenue Guidance for the Year 2024 CI
Establishment Labs Holdings Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Earnings Flash (ESTA) ESTABLISHMENT LABS HOLDINGS Reports Q4 Revenue $31.6M, vs. Street Est of $31.6M MT
Establishment Labs Announces Amended Credit Facility with Oaktree CI
Establishment Labs Holdings Inc. announced that it has received $49.999102 million in funding CI
Transcript : Establishment Labs Holdings Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 02:15 PM
Establishment Labs Launches $50 Million Private Placement; Reports Q4, 2023 Preliminary Revenue; Shares Rise 7% MT
Establishment Labs Holdings Inc. announced that it expects to receive $50 million in funding CI
Establishment Labs Holdings Inc. Announces First U.S. Commercial Procedure with Motiva Flora Tissue Expander CI
More news

Latest transcript on Establishment Labs Holdings Inc.

Logo Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc. Presents at Citi?s 2024 Unplugged Medtech and Life Sciences Access Day, Feb-29-2024 02:30 PM
More transcripts

Analyst Recommendations on Establishment Labs Holdings Inc.

Citigroup Raises Price Target on Establishment Labs to $60 From $49, Maintains Buy Rating MT
Mizuho Securities Raiset Price Target on Establishment Labs to $65 From $50, Keeps Buy Rating MT
TD Cowen Adjusts Establishment Labs Price Target to $60 From $50, Maintains Outperform Rating MT
B. Riley Lowers Establishment Labs Holdings' PT to $50 From $95 After Q3 Topline Miss, Notes Lower Multiple; Maintains Buy Rating MT
B. Riley Adjusts Establishment Labs Price Target to $95 From $107, Maintains Buy Rating MT
More recommendations

Press releases Establishment Labs Holdings Inc.

Establishment Labs to Announce First Quarter 2024 Financial Results on May 8 BU
Establishment Labs Announces Participation in The Aesthetic Meeting 2024 BU
Establishment Labs Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance BU
ESTABLISHMENT LABS ANNOUNCES PARTICIPATION IN TWO UPCOMING INVESTMENT CONFERENCES AQ
Establishment Labs Announces Participation in Two Upcoming Investment Conferences BU
More press releases

News in other languages on Establishment Labs Holdings Inc.

Tetra tech: Crecimiento alineado con los retos medioambientales
More news

Quotes and Performance

1 day-0.14%
1 week+2.30%
Current month-4.77%
1 month-2.47%
3 months+35.01%
6 months+59.97%
Current year+87.22%
More quotes

Highs and lows

1 week
44.86
Extreme 44.86
50.49
1 month
44.86
Extreme 44.86
55.73
Current year
24.42
Extreme 24.42
55.73
1 year
16.96
Extreme 16.96
73.00
3 years
16.96
Extreme 16.96
93.80
5 years
7.56
Extreme 7.56
93.80
10 years
7.56
Extreme 7.56
93.80
More quotes

Managers and Directors - Establishment Labs Holdings Inc.

Managers TitleAgeSince
Juan José Quirós CEO
 Chief Executive Officer 52 12-12-31
Raj Denhoy DFI
 Director of Finance/CFO 54 21-02-23
Roberto de Mezerville CTO
 Chief Tech/Sci/R&D Officer 44 08-12-31
Members of the board TitleAgeSince
Dennis Condon BRD
 Director/Board Member 75 17-11-30
Edward Schutter BRD
 Director/Board Member 72 15-07-31
Nicholas Lewin CHM
 Chairman 46 15-08-31
More insiders

ETFs positioned on Establishment Labs Holdings Inc.

Name Weight AuM 1st Jan change Investor Rating
FIRST TRUST IPOX EUROPE EQUITY OPPORTUNITIES ETF - DISTRIBUTING - USD ETF First Trust IPOX Europe Equity Opportunities ETF - Distributing - USD
0.10% 5 M€ +8.63%
SPDR MSCI WORLD SMALL CAP UCITS ETF - USD ETF SPDR MSCI World Small Cap UCITS ETF - USD
0.02% 773 M€ -.--% -
ARMOR US EQUITY INDEX ETF - USD ETF Armor US Equity Index ETF - USD
0.01% 9 M€ -.--% -
More ETFs positioned on Establishment Labs Holdings Inc.

Quotes

Date Price Change Volume
24-04-26 48.47 -0.14% 168,008
24-04-25 48.54 -0.84% 212,633
24-04-24 48.95 -1.49% 156,498
24-04-23 49.69 +2.94% 266,011
24-04-22 48.27 +1.88% 471,404

Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm

More quotes

Company Profile

Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.
Sector
Medical Equipment, Supplies & Distribution
Calendar
2024-05-02 - The Aesthetic Meeting
More about the company

Income Statement Evolution

More financial data

Ratings for Establishment Labs Holdings Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
48.47 USD
Average target price
59.29 USD
Spread / Average Target
+22.31%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ESTABLISHMENT LABS HOLDINGS INC. Stock Establishment Labs Holdings Inc.
+87.22% 1.33B
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. ESTA Stock